How medicines are distributed

There are three ways your patients can receive medications:

Using a Pharmacy Card

We will mail a Pharmacy Card directly to your patient’s home address. Your patient can then use the card, along with your prescription, to obtain the product from the pharmacy of their choice.

Shipped to a patient’s home

Certain medications are mailed directly to the patient’s home. Our specialty pharmacy will contact the patient directly to schedule the delivery.

Picking it up at your office

Certain medicines are sent directly to your office. Please work with your patient to find a time that is best for pick up.

How patients receive medicines depends on which ones they need. See the chart below to find out how your patient can receive theirs.

Where both Pharmacy Card & Doctor’s office are available, you can decide how you would prefer your patient to receive the medication. Please make that selection on the application.

Medication
Pharmacy Card
Doctor’s Office

BALVERSA™
(erdafitinib) Tablets

shipped directly to the patient’s home

CONCERTA® †
(methylphenidate HCI) Extended-Release Tablets CII

DARZALEX®
(daratumumab) Injection for intravenous infusion

ELMIRON®
(pentosan polysulfate sodium) Capsules

EDURANT®
(rilpivirine) Tablets

ERLEADA®
(apalutamide) Tablets

shipped directly to the patient’s home

HALDOL® †
(haloperidol) Immediate-Release Injection

HALDOL® Decanoate †
(haloperidol) IM Injection Only

IMBRUVICA®
(ibrutinib) Capsules/Tablets

shipped directly to the patient’s home

INTELENCE® 1
(etravirine) Tablets

INVEGA SUSTENNA® †
(paliperidone palmitate) Extended-Release Injectable Suspension

INVEGA TRINZA®
(paliperidone palmitate) Extended-Release Injectable Suspension

INVOKAMET® † 1
(canagliflozin/metformin HCI) Tablets

INVOKAMET® XR† 1
(canagliflozin/metformin HCI) Tablets

INVOKANA®† 1
(canagliflozin) Tablets

MONOVISC®
(high molecular weight hyaluronan) Injection

ORTHOVISC®
(high molecular weight hyaluronan) Injection

PREZCOBIX®1
(darunavir 800mg/cobicistat 150mg) Tablets

PREZISTA® 1
(darunavir) Tablets/Oral Suspension

PROCRIT® †
(epoetin alfa) Injection

REMICADE® †
(infliximab) IV Infusion

RISPERDAL CONSTA® †
(risperidone) Long-Acting Injection

SIMPONI® †
(golimumab) Injection

SIMPONI ARIA® †
(golimumab) IV Infusion

SIRTURO®
(bedaquiline) Tablets

SPORANOX® †
(itraconazole) Capsules

SPORANOX® †
(itraconazole) Oral Solution

SPRAVATO™ †
(esketamine) Nasal Spray, for intranasal use, CIII

STELARA®
(ustekinumab) Injection, for subcutaneous or intravenous use

SYMTUZA®
(darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Tablets

TREMFYA®
(guselkumab) Injection, for subcutaneous use

XARELTO® † 1
(rivaroxaban) Tablets

YONDELIS®
(trabectedin) Injection for intravenous infusion

ZYTIGA®
(abiraterone acetate) Tablets

shipped directly to the patient’s home

† Please see full U.S. prescribing information, including Black Box warning for: CONCERTA®, DOXIL®, HALDOL®, HALDOL® DECANOATE, INVEGA SUSTENNA®, INVEGA TRINZA®, INVOKAMET®, INVOKAMET® XR, INVOKANA®, PROCRIT®, REMICADE®, RISPERDAL CONSTA®, SIMPONI®, SIMPONI ARIA®, SPRAVATO, SPORANOX®, SPORANOX® ORAL SOLUTION, XARELTO®

1 These products are also available for hospital outpatients in our Hospital Access Patient Assistance Program